Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 562

1.

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63.

PMID:
10591302
2.

Medication management of stimulants in pediatric practice settings: a national perspective.

Hoagwood K, Jensen PS, Feil M, Vitiello B, Bhatara VS.

J Dev Behav Pediatr. 2000 Oct;21(5):322-31.

PMID:
11064959
3.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
4.

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.

Pediatrics. 2002 May;109(5):733-9.

PMID:
11986429
5.

Pharmacotherapy with atomoxetine for US children and adolescents.

Bhatara VS, Aparasu RR.

Ann Clin Psychiatry. 2007 Jul-Sep;19(3):175-80.

PMID:
17729019
6.
7.

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.

Robison LM, Sclar DA, Skaer TL, Galin RS.

Int Clin Psychopharmacol. 2004 Jan;19(1):17-22.

PMID:
15101565
8.

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.

Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.

Curr Med Res Opin. 2010 Apr;26(4):977-89. doi: 10.1185/03007991003673617.

PMID:
20178404
9.

National Ambulatory Medical Care Survey: 2001 summary.

Cherry DK, Burt CW, Woodwell DA.

Adv Data. 2003 Aug 11;(337):1-44.

PMID:
12924075
11.

Use of psychotropic medications for patients with office visits who receive a diagnosis of panic disorder.

Blanco C, Goodwin RD, Liebowitz MR, Schmidt AB, Lewis-Fernández R, Olfson M.

Med Care. 2004 Dec;42(12):1242-6.

PMID:
15550804
12.

Diagnostic practices for attention deficit hyperactivity disorder: a national survey of primary care physicians.

Chan E, Hopkins MR, Perrin JM, Herrerias C, Homer CJ.

Ambul Pediatr. 2005 Jul-Aug;5(4):201-8.

PMID:
16026184
14.

Use of medication by young people with attention-deficit/hyperactivity disorder.

Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA.

Med J Aust. 2002 Jul 1;177(1):21-5.

PMID:
12088474
15.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
16.
17.
18.

Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder.

Stevens J, Harman JS, Kelleher KJ.

J Dev Behav Pediatr. 2004 Oct;25(5):318-25.

PMID:
15502548
19.

Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.

Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC.

Arch Pediatr Adolesc Med. 1999 Oct;153(10):1039-45.

PMID:
10520611
20.

Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003.

Sankaranarayanan J, Puumala SE, Kratochvil CJ.

Curr Med Res Opin. 2006 Aug;22(8):1475-91.

PMID:
16870073

Supplemental Content

Support Center